1-13 of 13
R. Coleman Lindsley
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Risk of Bleeding in Essential Thrombocythemia Patients with Extreme Thrombocytosis

Rathnam K Venkat, Robert A Redd, Amyah C. Harris, Martin J Aryee, Anna E. Marneth, Baransel Kamaz, Chulwoo J Kim, Mohammed Wazir, Lachelle D. Weeks, Maximilian Stahl, Daniel J DeAngelo, R. Coleman Lindsley, Marlise R. Luskin, Gabriela S Hobbs, Joan How
Journal: Blood Advances
Blood Adv bloodadvances.2024013777.
https://doi.org/10.1182/bloodadvances.2024013777
Published: 2024
Includes: Supplemental data
Journal Articles

Intensive induction chemotherapy vs hypomethylating agents in combination with venetoclax in NPM1 -mutant AML

Jan Philipp Bewersdorf, Shai Shimony, Rory M. Shallis, Yiwen Liu, Guillaume Berton, Eva J. Schaefer, Amer M. Zeidan, Aaron D. Goldberg, Eytan M. Stein, Guido Marcucci, Rebecca P. Bystrom, R. Coleman Lindsley, Evan C. Chen, Jorge Ramos Perez, Anthony Stein, Vinod Pullarkat, Ibrahim Aldoss, Daniel J. DeAngelo, Donna S. Neuberg, Richard M. Stone, Sylvain Garciaz, Brian Ball, Maximilian Stahl
Journal: Blood Advances
Blood Adv (2024) 8 (18): 4845–4855.
https://doi.org/10.1182/bloodadvances.2024012858
Published: 2024
Includes: Supplemental data
Journal Articles

Prophylactic maintenance with venetoclax/azacitidine after reduced-intensity conditioning allogeneic transplant for high-risk MDS and AML

Clinical Trials & Observations
Jacqueline S. Garcia, Haesook T. Kim, H. Moses Murdock, Michela Ansuinelli, Jennifer Brock, Corey S. Cutler, Mahasweta Gooptu, Vincent T. Ho, John Koreth, Sarah Nikiforow, Rizwan Romee, Roman Shapiro, Daniel J. DeAngelo, Richard M. Stone, Denbaa Bat-Erdene, Jeremy Ryan, Manuel E. Contreras, Geoffrey Fell, Anthony Letai, Jerome Ritz, R. Coleman Lindsley, Robert J. Soiffer, Joseph H. Antin
Journal: Blood Advances
Blood Adv (2024) 8 (4): 978–990.
https://doi.org/10.1182/bloodadvances.2023012120
Published: 2024
Includes: Supplemental data
Journal Articles

FLT3-ITD does not predict inferior prognosis in acute myeloid leukemia patients aged ≥60 years

Clinical Trials & Observations
Shai Shimony, Geoffrey Fell, Evan C. Chen, Harrison K. Tsai, Martha Wadleigh, Eric S. Winer, Jacqueline S. Garcia, Marlise R. Luskin, Maximilian Stahl, Donna S. Neuberg, Daniel J. DeAngelo, R. Coleman Lindsley, Richard M. Stone
Journal: Blood Advances
Blood Adv (2023) 7 (18): 5354–5358.
https://doi.org/10.1182/bloodadvances.2023009748
Published: 2023
Includes: Supplemental data
Journal Articles

Utility of targeted gene sequencing to differentiate myeloid malignancies from other cytopenic conditions

Amy E. DeZern, Johannes B. Goll, R. Coleman Lindsley, Rafael Bejar, Steffanie H. Wilson, Donnie Hebert, Joachim Deeg, Ling Zhang, Steven Gore, Tareq Al Baghdadi, Jaroslaw Maciejewski, Jane Liu, Eric Padron, Rami Komrojki, Wael Saber, Gregory Abel, Steven H. Kroft, Alexandra Harrington, Tyler Grimes, Harrison Reed, Robert S. Fulton, Nancy L. DiFronzo, Nancy Gillis, Mikkael A. Sekeres, Matthew J. Walter
Journal: Blood Advances
Blood Adv (2023) 7 (14): 3749–3759.
https://doi.org/10.1182/bloodadvances.2022008578
Published: 2023
Includes: Supplemental data
Journal Articles

Allelic complexity of KMT2A partial tandem duplications in acute myeloid leukemia and myelodysplastic syndromes

Harrison K. Tsai, Christopher J. Gibson, H. Moses Murdock, Phani Davineni, Marian H. Harris, Eunice S. Wang, Lukasz P. Gondek, Annette S. Kim, Valentina Nardi, R. Coleman Lindsley
Journal: Blood Advances
Blood Adv (2022) 6 (14): 4236–4240.
https://doi.org/10.1182/bloodadvances.2022007613
Published: 2022
Includes: Supplemental data
Journal Articles

Prediction of life-threatening and disabling bleeding in patients with AML receiving intensive induction chemotherapy

Jurjen Versluis, Manu Pandey, Yael Flamand, J. Erika Haydu, Roger Belizaire, Mark Faber, Rahul S. Vedula, Anne Charles, Kevin M. Copson, Shai Shimony, Alon Rozental, Pavan K. Bendapudi, Ofir Wolach, Elizabeth A. Griffiths, James E. Thompson, Richard M. Stone, Daniel J. DeAngelo, Donna Neuberg, Marlise R. Luskin, Eunice S. Wang, R. Coleman Lindsley
Journal: Blood Advances
Blood Adv (2022) 6 (9): 2835–2846.
https://doi.org/10.1182/bloodadvances.2021006166
Published: 2022
Includes: Supplemental data
Journal Articles

Genomic profiling of a randomized trial of interferon-α vs hydroxyurea in MPN reveals mutation-specific responses

Clinical Trials & Observations
Trine Alma Knudsen, Vibe Skov, Kristen Stevenson, Lillian Werner, William Duke, Charles Laurore, Christopher J. Gibson, Anwesha Nag, Aaron R. Thorner, Bruce Wollison, Dennis Lund Hansen, Christina Ellervik, Daniel El Fassi, Karin de Stricker, Lukas Frans Ocias, Mette Brabrand, Ole Weis Bjerrum, Ulrik Malthe Overgaard, Mikael Frederiksen, Thomas Kielsgaard Kristensen, Torben A. Kruse, Mads Thomassen, Torben Mourits-Andersen, Marianne Tang Severinsen, Jesper Stentoft, Joern Starklint, Donna S. Neuberg, Lasse Kjaer, Thomas Stauffer Larsen, Hans Carl Hasselbalch, R. Coleman Lindsley, Ann Mullally
Journal: Blood Advances
Blood Adv (2022) 6 (7): 2107–2119.
https://doi.org/10.1182/bloodadvances.2021004856
Published: 2022
Includes: Supplemental data
Journal Articles

Adding venetoclax to fludarabine/busulfan RIC transplant for high-risk MDS and AML is feasible, safe, and active

Clinical Trials & Observations
Jacqueline S. Garcia, Haesook T. Kim, H. Moses Murdock, Corey S. Cutler, Jennifer Brock, Mahasweta Gooptu, Vincent T. Ho, John Koreth, Sarah Nikiforow, Rizwan Romee, Roman Shapiro, Fiona Loschi, Jeremy Ryan, Geoffrey Fell, Hannah Q. Karp, Fabienne Lucas, Annette S. Kim, Danielle Potter, Thelma Mashaka, Richard M. Stone, Daniel J. DeAngelo, Anthony Letai, R. Coleman Lindsley, Robert J. Soiffer, Joseph H. Antin
Journal: Blood Advances
Blood Adv (2021) 5 (24): 5536–5545.
https://doi.org/10.1182/bloodadvances.2021005566
Published: 2021
Includes: Supplemental data
Journal Articles

Somatic GATA2 mutations define a subgroup of myeloid malignancy patients at high risk for invasive fungal disease

Rahul S. Vedula, Matthew P. Cheng, Christine E. Ronayne, Dimitrios Farmakiotis, Vincent T. Ho, Sophia Koo, Francisco M. Marty, R. Coleman Lindsley, Tyler D. Bold
Journal: Blood Advances
Blood Adv (2020) 5 (1): 54–60.
https://doi.org/10.1182/bloodadvances.2020002854
Published: 2020
Includes: Supplemental data
Journal Articles

Stem cell donors should not be screened for clonal hematopoiesis

Christopher J. Gibson, R. Coleman Lindsley
Journal: Blood Advances
Blood Adv (2020) 4 (4): 789–792.
https://doi.org/10.1182/bloodadvances.2019000395
Published: 2020
Journal Articles

Recurrent genetic HLA loss in AML relapsed after matched unrelated allogeneic hematopoietic cell transplantation

Clinical Trials & Observations
Max Jan, Matthew J. Leventhal, Elizabeth A. Morgan, Jordan C. Wengrod, Anwesha Nag, Samantha D. Drinan, Bruce M. Wollison, Matthew D. Ducar, Aaron R. Thorner, Scott Leppanen, Jane Baronas, Jonathan Stevens, William J. Lane, Natasha Kekre, Vincent T. Ho, John Koreth, Corey S. Cutler, Sarah Nikiforow, Edwin P. Alyea, III, Joseph H. Antin, Robert J. Soiffer, Jerome Ritz, R. Coleman Lindsley, Benjamin L. Ebert
Journal: Blood Advances
Blood Adv (2019) 3 (14): 2199–2204.
https://doi.org/10.1182/bloodadvances.2019000445
Published: 2019
Includes: Supplemental data
Journal Articles

Systematic STAT3 sequencing in patients with unexplained cytopenias identifies unsuspected large granular lymphocytic leukemia

Elizabeth A. Morgan, Mark N. Lee, Daniel J. DeAngelo, David P. Steensma, Richard M. Stone, Frank C. Kuo, Jon C. Aster, Christopher J. Gibson, R. Coleman Lindsley
Journal: Blood Advances
Blood Adv (2017) 1 (21): 1786–1789.
https://doi.org/10.1182/bloodadvances.2017011197
Published: 2017
Includes: Supplemental data